E. Vestbo

1.1k total citations
17 papers, 929 citations indexed

About

E. Vestbo is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Vestbo has authored 17 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Nephrology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Vestbo's work include Chronic Kidney Disease and Diabetes (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). E. Vestbo is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). E. Vestbo collaborates with scholars based in Denmark, Cyprus and Australia. E. Vestbo's co-authors include Hans Ørskov, Jan Frystyk, Casper Skjærbæk, Carl Erik Mogensen, Sanne Fisker, Anders Frøland, Else Marie Skjøde Damsgaard, Steen Nielsen, Per Løgstrup Poulsen and Klavs Würgler Hansen and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

E. Vestbo

17 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Vestbo Denmark 9 526 279 262 205 142 17 929
Francesco Frigato Italy 12 463 0.9× 351 1.3× 110 0.4× 101 0.5× 578 4.1× 20 1.0k
Baihui Xu China 19 366 0.7× 241 0.9× 159 0.6× 108 0.5× 80 0.6× 31 985
Assumpta Serra Spain 14 245 0.5× 117 0.4× 95 0.4× 223 1.1× 376 2.6× 26 1.0k
Ridha Arem United States 18 717 1.4× 55 0.2× 146 0.6× 87 0.4× 71 0.5× 37 998
Jenie Yoonoo Hwang South Korea 19 287 0.5× 185 0.7× 141 0.5× 182 0.9× 56 0.4× 34 828
Yiting Xu China 17 246 0.5× 123 0.4× 221 0.8× 152 0.7× 80 0.6× 69 752
Ana E. Espinosa De Ycaza United States 14 594 1.1× 54 0.2× 82 0.3× 135 0.7× 116 0.8× 17 979
Maria R. Wing United States 15 128 0.2× 145 0.5× 445 1.7× 162 0.8× 426 3.0× 18 1.3k
Ei-Ichi Toda Japan 15 248 0.5× 306 1.1× 132 0.5× 95 0.5× 344 2.4× 23 919
Norman N. Chan Hong Kong 11 368 0.7× 183 0.7× 81 0.3× 68 0.3× 248 1.7× 14 876

Countries citing papers authored by E. Vestbo

Since Specialization
Citations

This map shows the geographic impact of E. Vestbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vestbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vestbo more than expected).

Fields of papers citing papers by E. Vestbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Vestbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vestbo. The network helps show where E. Vestbo may publish in the future.

Co-authorship network of co-authors of E. Vestbo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Vestbo. A scholar is included among the top collaborators of E. Vestbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Vestbo. E. Vestbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vestbo, E., Klaus Krogh, Páll Karlsson, et al.. (2021). [Diabetic neuropathy caused by too rapid downregulation of blood glucose].. Ugeskrift for Læger. 183(7). 1 indexed citations
2.
Olivarius, Niels de Fine, Anne Helms Andreasen, E. Vestbo, et al.. (2005). Urinary creatinine concentration is inversely related to glycaemic control and the presence of some diabetic complications in patients with newly diagnosed Type 2 diabetes. Journal of Diabetes and its Complications. 20(1). 45–50. 8 indexed citations
3.
Olivarius, Niels de Fine, Niels‐Henrik Holstein‐Rathlou, Volkert Siersma, et al.. (2004). Peripheral vascular disease is associated with reduced glycosuria in newly diagnosed type 2 diabetic patients. Diabetes & Metabolism. 30(3). 269–274. 3 indexed citations
4.
Vestbo, E., Anders Frøland, J. Ingerslev, et al.. (2002). Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects. Journal of Internal Medicine. 252(2). 155–163. 6 indexed citations
5.
Olivarius, Niels de Fine, E. Vestbo, Anne Helms Andreasen, & C. E. Mogensen. (2001). Renal involvement is related to body height in newly diagnosed diabetic women aged 40 years or over.. PubMed. 27(1). 14–8. 7 indexed citations
8.
Frystyk, Jan, Casper Skjærbæk, E. Vestbo, Sanne Fisker, & Hans Ørskov. (1999). Circulating levels of free insulin-like growth factors in obese subjects: the impact of Type 2 diabetes. Diabetes/Metabolism Research and Reviews. 15(5). 314–322. 252 indexed citations
9.
Vestbo, E.. (1999). [Wisdom--knowledge, the patient and the physician].. PubMed. 119(8). 1146–8. 1 indexed citations
10.
Vestbo, E., Else Marie Skjøde Damsgaard, & Carl Erik Mogensen. (1997). The relationship between microalbuminuria in first generation diabetic and non-diabetic subjects and microalbuminuria and hypertension in the second generation (a population based study).. PubMed. 12 Suppl 2. 32–6. 6 indexed citations
11.
Vestbo, E., Else Marie Skjøde Damsgaard, Anders Frøland, & Carl Erik Mogensen. (1996). Birth weight and cardiovascular risk factors in an epidemiological study. Diabetologia. 39(12). 1598–1602. 38 indexed citations
12.
Fisker, Sanne, Jan Frystyk, Lars Skriver, et al.. (1996). A simple, rapid immunometric assay for determination of functional and growth hormone‐occupied growth hormone‐binding protein in human serum. European Journal of Clinical Investigation. 26(9). 779–785. 61 indexed citations
13.
Vestbo, E., Else Marie Skjøde Damsgaard, Anders Frøland, & Carl Erik Mogensen. (1996). Clinical features in persons with a family history of diabetes compared to controls (The Second Generation Fredericia Study). Journal of Internal Medicine. 240(6). 381–387. 6 indexed citations
14.
Vestbo, E., Else Marie Skjøde Damsgaard, Anders Frøland, & Carl Erik Mogensen. (1995). Urinary Albumin Excretion in a Population Based Cohort. Diabetic Medicine. 12(6). 488–493. 22 indexed citations
15.
Frystyk, Jan, E. Vestbo, Casper Skjærbæk, Carl Erik Mogensen, & Hans Ørskov. (1995). Free insulin-like growth factors in human obesity. Metabolism. 44(10 Suppl 4). 37–44. 288 indexed citations
16.
Mogensen, Carl Erik, E. Vestbo, Per Løgstrup Poulsen, et al.. (1995). Microalbuminuria and Potential Confounders: A review and some observations on variability of urinary albumin excretion. Diabetes Care. 18(4). 572–581. 182 indexed citations
17.
Vestbo, E., Else Marie Skjøde Damsgaard, Anders Frøland, & C. E. Mogensen. (1994). Microalbuminuria in a population-based cohort: Ways of expression of albuminuria (Fredericia study — Second generation). Journal of Diabetes and its Complications. 8(3). 176–177. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026